Intellia Therapeutics (NASDAQ:NTLA) Q2 2020 Earnings Conference Call August 5, 2020 8:00 AM ET
Company Participants
Lina Li - Associate Director, IR
John Leonard - President, CEO & Director
Laura Sepp-Lorenzino - EVP & Chief Scientific Officer
Glenn Goddard - EVP & CFO
Conference Call Participants
Maurice Raycroft - Jefferies
Xiaochuan Dai - Barclays Bank
Madhu Kumar - Robert W. Baird & Co.
Timur Ivannikov - Raymond James & Associates
Jay Olson - Oppenheimer
Operator
Good morning. My name is Rachel, and I will be your conference operator today. Welcome to the Intellia Therapeutics Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request. At this time, I would like to turn it over To Lina Li, Associate Director of Investor Relations at Intellia. Please go ahead.
Lina Li
Thank you, operator. Good morning, everyone, and welcome to Intellia's Second Quarter 2020 Earnings Call. Today, we are coming to you from different locations, and we ask that you please bear with us in the event that we have any audio interruptions on the call. Earlier this morning, we issued a press release outlining our progress this quarter and the topics we plan to discuss on today's call. This release can be found on the Investors and Media section of our website at intelliatx.com. This call is being broadcast live and a replay will also be archived on our website.
Before we get started, I would like to remind you that during this call, we may make certain forward-looking statements and ask that you refer to our SEC filings available at sec.gov for a discussion of potential risks and uncertainties. All information presented on this call is current as of today, and Intellia undertakes no duty to update this information unless required by
- Read more current NTLA analysis and news
- View all earnings call transcripts